Edwards Lifesciences Corporation EW
$ 70.54
1.43%
Quarterly report 2024-Q3
added 11-06-2024
Edwards Lifesciences Corporation Cash Flow 2011-2024 | EW
Annual Cash Flow Edwards Lifesciences Corporation
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
896 M | 1.22 B | 1.73 B | 1.05 B | 1.18 B | 927 M | 1 B | 704 M | 550 M | - | - | - | - |
Depreciation & Amortization |
145 M | 140 M | 135 M | 107 M | 89.3 M | 77.4 M | 81.9 M | 71.2 M | 65.8 M | 68.6 M | 62.9 M | 53.7 M | 58 M |
Accounts Payables |
201 M | 202 M | 204 M | 196 M | 180 M | 134 M | 117 M | 97.1 M | 63.9 M | 58.2 M | 48.4 M | 74.7 M | 85 M |
Accounts Receivables |
775 M | 643 M | 582 M | 515 M | 544 M | 457 M | 422 M | 366 M | 315 M | 288 M | 302 M | 321 M | 284 M |
Total Inventories |
1.17 B | 876 M | 727 M | 802 M | 641 M | 607 M | 555 M | 397 M | 340 M | 297 M | 309 M | 281 M | 261 M |
All numbers in USD currency
Quarterly Cash Flow Edwards Lifesciences Corporation
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -53.5 M | - | - | - | 314 M | - | 935 M | - | 293 M | - | 1.36 B | - | 300 M | - | 654 M | 438 M | 207 M | - | 780 M | 343 M | 1.5 M | - | 634 M | 292 M | 151 M | - | 637 M | 326 M | 128 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.9 M |
Depreciation & Amortization |
- | - | 38.5 M | - | - | - | 35.2 M | - | 104 M | - | 34.7 M | - | 102 M | - | 32.4 M | - | 74.6 M | 49 M | 24.5 M | - | 65.4 M | 42.3 M | 20.6 M | - | 57.5 M | 38.3 M | 19.1 M | - | 60.7 M | 40 M | 21.1 M | - | 52.1 M | 33.9 M | 15.9 M | - | 51.3 M | 32.8 M | 16 M | - | 50.3 M | 32.3 M | 16.2 M | - | 45.8 M | 28.8 M | 14.1 M | - | 42.2 M | 27.8 M | 13.8 M | - | 43.2 M | 29.3 M | 14.5 M |
Accounts Payables |
173 M | 186 M | 212 M | 187 M | 191 M | 193 M | 181 M | 202 M | 155 M | - | 159 M | 204 M | 140 M | 145 M | 150 M | 196 M | 196 M | 196 M | 196 M | 180 M | 180 M | 180 M | 180 M | 134 M | 134 M | 134 M | 134 M | 117 M | 117 M | 117 M | 117 M | 97.1 M | 97.1 M | 97.1 M | 97.1 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 58.2 M | 58.2 M | 58.2 M | 58.2 M | 48.4 M | 48.4 M | - | - | 74.7 M | - | - | - | 85 M | - | - | - |
Accounts Receivables |
716 M | 778 M | 818 M | 772 M | 740 M | 754 M | 718 M | 643 M | 618 M | - | 636 M | 582 M | 601 M | 640 M | 587 M | 515 M | 515 M | 515 M | 515 M | 544 M | 544 M | 610 M | 599 M | 457 M | 424 M | 431 M | 407 M | 439 M | 439 M | 439 M | 422 M | 366 M | 454 M | 415 M | 415 M | 315 M | 338 M | 344 M | 344 M | 288 M | 323 M | 325 M | 325 M | 302 M | 328 M | 328 M | 328 M | 321 M | 325 M | 336 M | 347 M | 321 M | 347 M | 321 M | 321 M |
Total Inventories |
1.1 B | 1.02 B | 1.21 B | 904 M | 1.03 B | 980 M | 914 M | 876 M | 758 M | - | 731 M | 727 M | 738 M | 760 M | 768 M | 802 M | 802 M | 802 M | 802 M | 641 M | 641 M | 641 M | 641 M | 607 M | 607 M | 607 M | 607 M | 555 M | 555 M | 555 M | 555 M | 397 M | 397 M | 397 M | 397 M | 340 M | 340 M | 340 M | 340 M | 297 M | 297 M | 297 M | 297 M | 309 M | 309 M | 309 M | 309 M | 281 M | 281 M | 281 M | 281 M | 261 M | 261 M | 261 M | 261 M |
All numbers in USD currency